Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3870148 | The Journal of Urology | 2008 | 5 Pages |
Abstract
While a microfocus of Gleason score 6 prostate cancer on biopsy is commonly considered low risk disease, there was a greater than 1/5 risk of pathological upgrading and/or up staging. Patients with Gleason score 6 microfocal prostate cancer should be counseled that they may harbor more aggressive disease, especially when pretreatment clinical risk factors are present, such as advanced age or high clinical prostate specific antigen density.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Alan E. Thong, Sergey Shikanov, Mark H. Katz, Ofer N. Gofrit, Scott Eggener, Gregory P. Zagaja, Arieh L. Shalhav, Kevin C. Zorn,